Skip to content
O

Obiageri Ihuarulam Okeoma

0009-0004-3302-7370

Publications (4)

Hormonal and Genetic Influences on Benign Reproductive Tumours in Young Women: A Narrative Review

Obiageri Ihuarulam Okeoma, Godwin Kenechukwu Nwajiugo, Uchechukwu Mercy Ejike, Oluwafunmilayo E. O. Adetona, Uchechukwu Lilian Okoye, Yolanda Molkuh Emmanuel & Lydia Amarachi Onwuemelem · International Research Journal of Oncology · 2026

Background: Benign reproductive tumours, such as uterine fibroids, ovarian cysts and endometrial polyps, are extremely common in women of childbearing age and contribute to gynaecological morbidity to a significant degree. Among these, uterine fibroids demonstrate a cumulative li...

Open access Research Article 10.9734/irjo/2026/v9i1207

Silent Multiorgan Injury in Sickle Cell Disease: Redefining Mortality Beyond Pain Crises

Daniel Obinna Eke, Obiageri Ihuarulam Okeoma, Leo Tata, Salamah Abimbola Junaid, Williams Temidayo Solomon & Esther Uyoyooghene Olokede · International Journal of Research and Reports in Hematology · 2026

Sickle cell disease (SCD) has typically been seen through the prism of acute vaso-occlusive crises and other clinically noticeable issues that call for medical attention. The mortality rate among people with sickle cell disease (SCD) is still much higher than that of the general...

Open access Research Article 10.9734/ijr2h/2026/v9i2224

Extended Half-life Versus Standard Half-life Factor Replacement Therapy in Hemophilia A and B: A Systematic Review and Meta-analysis

Kwesi Akonu Adom Mensah Forson, Obiageri Ihuarulam Okeoma, Oluchi Okechukwu, Chidinma Lorretta Gab-Obinna, Enobong Edoabasi Obong, Richard Afriyie Osei & Jazuli Isyaku Bala · International Journal of Research and Reports in Hematology · 2026

Hemophilia is a congenital bleeding disorder that requires frequent factor replacement therapies to manage bleeding episodes. This systematic review and meta-analysis compares the efficacy of extended half-life (EHL) and standard half-life (SHL) factor replacement therapies in pa...

Open access Research Article 10.9734/ijr2h/2026/v9i1215

Next-Gen Gene Editing and Programmable Chromosome Engineering for Potential Cancer Gene Mutation Therapeutics

Salvation Ifechukwude Atalor, Jumoke Ologun, Modinat Aina, Abayomi, Obiageri Ihuarulam Okeoma, Opeoluwa Alayande, Awah Favour Matthew, Reginald Oyortey & Lawrence John AJutor · International Research Journal of Oncology · 2025

Gene editing technologies have revolutionized the approach to treating cancer by enabling precise modifications to the genome, particularly through programmable chromosome engineering techniques that allow for large-scale rearrangements, deletions, and insertions to correct or di...

Open access Research Article 10.9734/irjo/2025/v8i2187